foxo4-dri senolytic peptide mouse model 2024

foxo4-dri senolytic peptide mouse model 2024 FOXO4-DRI: Human Trial Status, Cancer Research & Data FOXO4-DRI Peptide - Nationwide Peptides

Name: foxo4-dri senolytic peptide mouse model 2024 FOXO4-DRI: Human Trial Status, Cancer Research & Data FOXO4-DRI Peptide - Nationwide Peptides
Brand: vanxuanam.com
SKU: 30304686972
Price: 20.83 USD
Availability: InStock
Rating: 4.3483 (5 reviews)

FOXO4 DRI Peptide Nationwide Peptides By National Science Labs, LLC Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC

SKU: 30304686972 · From vanxuanam.com

4.3

USD20.83 USD46.83

Pay in 4 interest-free payments of $5.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Chronic exposure exacerbates these symptoms through mechanisms, such as oxidative stress, excitotoxicity, and mitochondrial dysfunction, in the nigrostriatal pathway (Yang et al., 2018)